News & Blog
What if there was a disease affecting 27.1 million people in the United States, that killed over 33,000 people in one year or about 91 people a day? What if this same disease cost the United States healthcare system about $78.5 billion? What if researchers could not study this disease in order to provide information […]
Medicare rang in the new year with four new codes to reimburse primary care teams for behavioral health services. According to an article that appeared in the New England Journal of Medicine on February 2, 2017, three of the codes support services using the Collaborative Care Model (CoCM) and the fourth allows for services provided […]
Pilot grant awardee Dr. Karen Lasser and her team have developed an intervention to screen, link and treat patients with hepatitis C (HCV) in the primary care setting. As the founding medical director for HCV treatment in primary care, Dr. Lasser was motivated to do a budget impact analysis of their intervention to analyze whether the […]
The Center for Health Economics of Treatment Interventions for Substance Use Disorders, HCV, and HIV (CHERISH) was profiled at the Liver Meeting® 2016 in Boston, MA. The Center’s mission is to develop and disseminate health economic research on healthcare utilization, health outcomes, and health-related behaviors that informs substance use disorder treatment policy and HCV and […]
Last week the Surgeon General, Dr. Vivek Murthy, released the groundbreaking, comprehensive report Facing Addiction in America: The Surgeon General’s Report on Alcohol, Drugs, and Health. The report comes at a critical juncture, with more than 27 million Americans misusing illicit and prescription drugs, and more than 66 million misusing alcohol. The Surgeon General details […]
The US Panel on Cost-Effectiveness in Health and Medicine issued a report in 1996 that set the standards for reporting of cost-effectiveness studies in the field, resulting in a rapid expansion of publications and establishment of similar national standards in other jurisdictions. Twenty years later, the Second Panel on Cost-Effectiveness in Health and Medicine has […]